Floatz logo

Dipyridamole

Basal Ganglia Disease

Insel Gruppe AG, University Hospital BernSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Basal Ganglia Disease cohort.

Asset / SponsorPhaseRating
Vy-Aadc01
Neurocrine Biosciences
Phase 1CC
Plavix
Insel Gruppe AG, University Hospital Bern
N/AD
Acetylsalicylic Acid
Insel Gruppe AG, University Hospital Bern
N/AD

Same molecule, other indications

Dipyridamole is also rated in:

venous thromboembolismDormant
BB
Indicative ·
71 / 100
View asset →
brain ischemiaDormant
BB
Indicative ·
68 / 100
View asset →
portal hypertensionDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →